165 related articles for article (PubMed ID: 32430486)
1. Perhexiline Demonstrates FYN-mediated Antitumor Activity in Glioblastoma.
Kant S; Kesarwani P; Guastella AR; Kumar P; Graham SF; Buelow KL; Nakano I; Chinnaiyan P
Mol Cancer Ther; 2020 Jul; 19(7):1415-1422. PubMed ID: 32430486
[TBL] [Abstract][Full Text] [Related]
2. MET Inhibition Elicits PGC1α-Dependent Metabolic Reprogramming in Glioblastoma.
Zhang Y; Nguyen TTT; Shang E; Mela A; Humala N; Mahajan A; Zhao J; Shu C; Torrini C; Sanchez-Quintero MJ; Kleiner G; Bianchetti E; Westhoff MA; Quinzii CM; Karpel-Massler G; Bruce JN; Canoll P; Siegelin MD
Cancer Res; 2020 Jan; 80(1):30-43. PubMed ID: 31694905
[TBL] [Abstract][Full Text] [Related]
3. Targeting PDGFRα-activated glioblastoma through specific inhibition of SHP-2-mediated signaling.
Sang Y; Hou Y; Cheng R; Zheng L; Alvarez AA; Hu B; Cheng SY; Zhang W; Li Y; Feng H
Neuro Oncol; 2019 Nov; 21(11):1423-1435. PubMed ID: 31232447
[TBL] [Abstract][Full Text] [Related]
4. Alantolactone induces apoptosis in glioblastoma cells via GSH depletion, ROS generation, and mitochondrial dysfunction.
Khan M; Yi F; Rasul A; Li T; Wang N; Gao H; Gao R; Ma T
IUBMB Life; 2012 Sep; 64(9):783-94. PubMed ID: 22837216
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor 13 regulates glioma cell invasion and is important for bevacizumab-induced glioma invasion.
Otani Y; Ichikawa T; Kurozumi K; Inoue S; Ishida J; Oka T; Shimizu T; Tomita Y; Hattori Y; Uneda A; Matsumoto Y; Michiue H; Date I
Oncogene; 2018 Feb; 37(6):777-786. PubMed ID: 29059154
[TBL] [Abstract][Full Text] [Related]
6. Enhanced expression of proapoptotic and autophagic proteins involved in the cell death of glioblastoma induced by synthetic glycans.
Faried A; Arifin MZ; Ishiuchi S; Kuwano H; Yazawa S
J Neurosurg; 2014 Jun; 120(6):1298-308. PubMed ID: 24678780
[TBL] [Abstract][Full Text] [Related]
7. Dual Inhibition of Bcl-2/Bcl-xL and XPO1 is synthetically lethal in glioblastoma model systems.
Shang E; Zhang Y; Shu C; Ishida CT; Bianchetti E; Westhoff MA; Karpel-Massler G; Siegelin MD
Sci Rep; 2018 Oct; 8(1):15383. PubMed ID: 30337641
[TBL] [Abstract][Full Text] [Related]
8. Induction of Mitochondrial Dysfunction and Oxidative Damage by Antibiotic Drug Doxycycline Enhances the Responsiveness of Glioblastoma to Chemotherapy.
Tan Q; Yan X; Song L; Yi H; Li P; Sun G; Yu D; Li L; Zeng Z; Guo Z
Med Sci Monit; 2017 Aug; 23():4117-4125. PubMed ID: 28842551
[TBL] [Abstract][Full Text] [Related]
9. Demethoxycurcumin analogue DMC-BH exhibits potent anticancer effects on orthotopic glioblastomas.
Shi L; Sun G; Zhang Y
Aging (Albany NY); 2020 Nov; 12(23):23795-23807. PubMed ID: 33221748
[TBL] [Abstract][Full Text] [Related]
10. 6-MOMIPP, a novel brain-penetrant anti-mitotic indolyl-chalcone, inhibits glioblastoma growth and viability.
Du S; Sarver JG; Trabbic CJ; Erhardt PW; Schroering A; Maltese WA
Cancer Chemother Pharmacol; 2019 Feb; 83(2):237-254. PubMed ID: 30426158
[TBL] [Abstract][Full Text] [Related]
11. ω3-polyunsaturated fatty acids induce cell death through apoptosis and autophagy in glioblastoma cells: In vitro and in vivo.
Kim S; Jing K; Shin S; Jeong S; Han SH; Oh H; Yoo YS; Han J; Jeon YJ; Heo JY; Kweon GR; Park SK; Park JI; Wu T; Lim K
Oncol Rep; 2018 Jan; 39(1):239-246. PubMed ID: 29192322
[TBL] [Abstract][Full Text] [Related]
12. IKBKE enhances TMZ-chemoresistance through upregulation of MGMT expression in glioblastoma.
Guo G; Sun Y; Hong R; Xiong J; Lu Y; Liu Y; Lu J; Zhang Z; Guo C; Nan Y; Huang Q
Clin Transl Oncol; 2020 Aug; 22(8):1252-1262. PubMed ID: 31865606
[TBL] [Abstract][Full Text] [Related]
13. Nuclear factor I A promotes temozolomide resistance in glioblastoma via activation of nuclear factor κB pathway.
Yu X; Wang M; Zuo J; Wahafu A; Mao P; Li R; Wu W; Xie W; Wang J
Life Sci; 2019 Nov; 236():116917. PubMed ID: 31614149
[TBL] [Abstract][Full Text] [Related]
14. Novel MET/TIE2/VEGFR2 inhibitor altiratinib inhibits tumor growth and invasiveness in bevacizumab-resistant glioblastoma mouse models.
Piao Y; Park SY; Henry V; Smith BD; Tiao N; Flynn DL; de Groot JF
Neuro Oncol; 2016 Sep; 18(9):1230-41. PubMed ID: 26965451
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of GLO1 in Glioblastoma Multiforme Increases DNA-AGEs, Stimulates RAGE Expression, and Inhibits Brain Tumor Growth in Orthotopic Mouse Models.
Jandial R; Neman J; Lim PP; Tamae D; Kowolik CM; Wuenschell GE; Shuck SC; Ciminera AK; De Jesus LR; Ouyang C; Chen MY; Termini J
Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29385725
[TBL] [Abstract][Full Text] [Related]
16. miR-423-5p contributes to a malignant phenotype and temozolomide chemoresistance in glioblastomas.
Li S; Zeng A; Hu Q; Yan W; Liu Y; You Y
Neuro Oncol; 2017 Jan; 19(1):55-65. PubMed ID: 27471108
[TBL] [Abstract][Full Text] [Related]
17. NT5DC2 promotes tumorigenicity of glioma stem-like cells by upregulating fyn.
Guo S; Ran H; Xiao D; Huang H; Mi L; Wang X; Chen L; Li D; Zhang S; Han Q; Zhou T; Li A; Man J
Cancer Lett; 2019 Jul; 454():98-107. PubMed ID: 30978441
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol sensitizes glioblastoma-initiating cells to temozolomide by inducing cell apoptosis and promoting differentiation.
Li H; Liu Y; Jiao Y; Guo A; Xu X; Qu X; Wang S; Zhao J; Li Y; Cao Y
Oncol Rep; 2016 Jan; 35(1):343-51. PubMed ID: 26498391
[TBL] [Abstract][Full Text] [Related]
19. T-Type Ca
Visa A; Sallán MC; Maiques O; Alza L; Talavera E; López-Ortega R; Santacana M; Herreros J; Cantí C
Cancer Res; 2019 Apr; 79(8):1857-1868. PubMed ID: 30755443
[TBL] [Abstract][Full Text] [Related]
20. Amlexanox, a selective inhibitor of IKBKE, generates anti-tumoral effects by disrupting the Hippo pathway in human glioblastoma cell lines.
Liu Y; Lu J; Zhang Z; Zhu L; Dong S; Guo G; Li R; Nan Y; Yu K; Zhong Y; Huang Q
Cell Death Dis; 2017 Aug; 8(8):e3022. PubMed ID: 29048430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
